ACI’s services have supported more than 20 product approvals in many different therapeutic areas throughout our history. Projects have been conducted for top 10 global pharmaceutical companies, major academic institutions, and several biotech, medical device and diagnostics companies.
We are proud to have partnered with such an expansive client base and to have supported the following regulatory-approved products:
Product | Indication | ACI Services |
Budesonide/formoterol fumarate dihydrate | Asthma and COPD | DMC |
Varenicline | Smoking cessation | EAC |
Teduglutide | Short Bowel Syndrome | Data Services |
Donepezil HCI Drug delivery device | Alzheimer’s | Data Services |
Alemtuzumab | Multiple Sclerosis | EAC |
Afatinib | NSCLC | DMC |
Dalfampridine | Multiple Sclerosis | DMC |
Iontophoretic Drug delivery device | Pain | Data Services, Stats |
Tiotropium bromide inhalation powder | COPD | EAC, DMC |
Darbepoetin alfa | Breast cancer | Data Services |
Defibrotide | Hepatic VOD | Data Services |
Dimethyl fumarate | Multiple Sclerosis | EAC |
Vitespen | Cancer vaccine | DMC |
Methylphenidate | ADHD | Data Services, Stats |
Tetrabenazine | Huntington’s disease | Cardiac Safety Advisory |
Dronedarone | Atrial fibrillation (AFib) | DMC |
Linagliptin | Diabetes | EAC |
Computer-Assisted Personalized Sedation System | Anesthesiology | DMC |
Lurasidone HCI | Schizophrenia | Stats, CDISC conversion |
Epoetin Alfa | Anemia | DMC |
Mobile Cardiac Outpatient Telemetry Diagnostic Monitor | Cardiac arrhythmia | Advisory Services, Data Services |